145
Participants
Start Date
February 14, 2022
Primary Completion Date
March 21, 2024
Study Completion Date
March 21, 2024
EN3835
Treatment or retreatment with EN3835
Endo Clinical Trial Site #9, York
Endo Clinical Trial Site #12, Bakersfield
Endo Clinical Trial Site #6, Pasadena
Endo Clinical Trial Site #20, Suffolk
Endo Clinical Trial Site #22, Lawrenceville
Endo Clinical Trial Site #21, Sweetwater
Endo Clinical Trial Site #24, Miami
Endo Clinical Trial Site #8, Pinellas Park
Endo Clinical Trial Site #2, O'Fallon
Endo Clinical Trial Site #19, Decatur
Endo Clinical Trial Site #14, Springfield
Endo Clinical Trial Site #16, Jefferson City
Endo Clinical Trial Site #17, Dallas
Endo Clinical Trial Site #26, Dallas
Endo Clinical Trial Site #4, Bedford
Endo Clinical Trial Site #5, Fort Worth
Endo Clinical Trial Site #7, Houston
Endo Clinical Trial Site #10, Houston
Endo Clinical Trial Site #1, McAllen
Endo Clinical Trial Site #27, Georgetown
Endo Clinical Trial Site #25, Meridian
Endo Clinical Trial Site #11, Salt Lake City
Endo Clinical Trial Site #18, Whittier
Endo Clinical Trial Site #13, Tarzana
Endo Clinical Trial Site #23, La Mesa
Endo Clinical Trial Site #15, Vista
Endo Clinical Trial Site #3, Fresno
Lead Sponsor
Endo Pharmaceuticals
INDUSTRY